Publications

5808 Results

Southwest Oncology Group Phase II-III gastric cancer study: 5-Fluorouracil, Adriamycin, and Mitomycin-C + Vincristine (FAM vs V-FAM) compared to chlorozotocin (CZT), m-AMSA, and Dihydroxyanthracenedione (DHAD) with unimpressive differences.

Authors
C Haas;N Oishi;B McDonald;C Coltman;R O'Bryan
Journal / Conference
ASCO #C-478
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7841

Evaluation of 5-FU vs. a Phase II drug in metastatic adenocarcinoma of the large bowel: Southwest Oncology Group (SWOG) study 7940.

Authors
L Leichman;C Fabian;R O'Bryan;JT Guy;W Fletcher;R Shildt;JD McCracken;T Chen
Journal / Conference
ASCO #C-469
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7940/45

AZQ in the treatment of colon cancer - A Southwest Oncology Group study.

Authors
R Shildt;J Bonnet;W Fletcher
Journal / Conference
ASCO #C-496
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7940/45

Phase II trial of 5FU, Adriamycin, Cyclophosphamide, and Streptozotocin (FAC-S) in metastatic carcinoid (for the Southwest Oncology Group).

Authors
RM Bukowski;R Stephens;N Oishi;R Petersen;T Chen
Journal / Conference
ASCO #C-510
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8017

The Southwest Oncology Group experience. Adjuvant therapy for stage IB and II non-seminomatous testicular cancer.

Authors
RL Stephens;CA Coltman Jr;J Neidhart;J Mullins;J Frank
Journal / Conference
Int J Rad Onc Bio Phys 9:1885-1890
Year
1983
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-7525

Adriamycin versus adriamycin plus cis-diamminedichloro- platinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group study.

Authors
R Gagliano;H Levin;MN El-Bolkainy;HE Wilson;RL Stephens;WS Fletcher;SE Rivkin;RM O'Bryan;CA Coltman Jr;JH Saiki;WJ Stuckey;L Balducci;JD Bonnet;DO Dixon
Journal / Conference
Am J Clin Oncol (CCT) 6(2): 215-218
Year
1983
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-7624

Mitoguazone in advanced renal carcinoma. A Phase II trial of the Southwest Oncology Group.

Authors
WA Knight III;A Drelichman;C Fabian;RM Bukowski
Journal / Conference
Cancer Treat Rep 67:1139-1140
Year
1983
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-7959

Mitoxantrone: Modest activity in a Phase II trial in advanced prostate cancer.

Authors
CK Osborne;A Drelichman;DD Von Hoff;ED Crawford
Journal / Conference
Cancer Treat Rep 67:1133-1135
Year
1983
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8010

Southwest Oncology Group experience with 5-fluorouracil in carcinoma of the colon.

Authors
JD McCracken;TT Chen;LP Leichman;VK Vaitkevicius
Journal / Conference
13th International Congress of Chemotherapy (Vienna, September 2, 1983), Part 259, SE 12.1 20-8
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7434, SWOG-7801, SWOG-7940/45

Hexamethylmelamine (HEX) vs. Flourouracil, Adriamycin and Cytoxan (FAC) in advanced bladder cancer - A SWOG study.

Authors
ED Crawford;R Gagliano;J Frank
Journal / Conference
ASCO #C-518
Year
1983
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-7904